These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26147344)

  • 1. Differential Effect of Oxicam Non-Steroidal Anti-Inflammatory Drugs on Membranes and Their Consequence on Membrane Fusion.
    Majumdar A; Kundu D; Sarkar M
    J Phys Chem B; 2015 Jul; 119(30):9627-39. PubMed ID: 26147344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of increase in orientational order of lipid chains and head group spacing on non steroidal anti-inflammatory drug induced membrane fusion.
    Roy SM; Bansode AS; Sarkar M
    Langmuir; 2010 Dec; 26(24):18967-75. PubMed ID: 21114267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
    Mondal Roy S; Sarkar M
    Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane fusion: a new function of non steroidal anti-inflammatory drugs.
    Chakraborty H; Mondal S; Sarkar M
    Biophys Chem; 2008 Sep; 137(1):28-34. PubMed ID: 18617319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-steroidal anti-inflammatory drug induced membrane fusion: concentration and temperature effects.
    Mondal S; Sarkar M
    J Phys Chem B; 2009 Dec; 113(51):16323-31. PubMed ID: 19954169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Mismatches in Fatty Acyl Tail Lengths Can Effect Non Steroidal Anti-Inflammatory Drug Induced Membrane Fusion.
    Majumdar A; Sarkar M
    J Phys Chem B; 2016 Jun; 120(21):4791-802. PubMed ID: 27153337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of non steroidal anti-inflammatory drug induced membrane fusion by copper coordination of these drugs: anchoring effect.
    Majumdar A; Chakraborty S; Sarkar M
    J Phys Chem B; 2014 Dec; 118(48):13785-99. PubMed ID: 25380501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs.
    Chakraborty H; Roy S; Sarkar M
    Chem Phys Lipids; 2005 Dec; 138(1-2):20-8. PubMed ID: 16183046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic probing of model lipid membranes: phospholipase A2 activity toward monolayers modified by oxicam NSAIDs.
    Czapla K; Korchowiec B; Orlof M; Magnieto JR; Rogalska E
    J Phys Chem B; 2011 Jul; 115(29):9290-8. PubMed ID: 21682312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nonsteroidal anti-inflammatory drugs on the cellular membrane fluidity.
    Sousa C; Nunes C; Lúcio M; Ferreira H; Lima JL; Tavares J; Cordeiro-da-Silva A; Reis S
    J Pharm Sci; 2008 Aug; 97(8):3195-206. PubMed ID: 17990311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of new oxicam derivatives with lipid bilayers as measured by calorimetry and fluorescence spectroscopy.
    Maniewska J; Gąsiorowska J; Szczęśniak-Sięga B; Michalak K
    Acta Biochim Pol; 2018; 65(2):185-191. PubMed ID: 29796443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of non-steroid anti-inflammatory drugs in membrane bilayers.
    Kyrikou I; Hadjikakou SK; Kovala-Demertzi D; Viras K; Mavromoustakos T
    Chem Phys Lipids; 2004 Dec; 132(2):157-69. PubMed ID: 15555602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating oxicam nonsteroidal anti-inflammatory drugs in phosphoglyceride monolayers.
    Czapla K; Korchowiec B; Rogalska E
    Langmuir; 2010 Mar; 26(5):3485-92. PubMed ID: 20030324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of nonsteroidal anti-inflammatory drugs with membranes: in vitro assessment and relevance for their biological actions.
    Pereira-Leite C; Nunes C; Reis S
    Prog Lipid Res; 2013 Oct; 52(4):571-84. PubMed ID: 23981364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of NSAIDs in micelles: implication of structural switchover in drug-membrane interaction.
    Chakraborty H; Banerjee R; Sarkar M
    Biophys Chem; 2003 May; 104(1):315-25. PubMed ID: 12834850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of individual choice of NSAIDs on the example of the oxicam class, taking into account clinical and pharmacological characteristics].
    Putilina MV; Teplova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):36-41. PubMed ID: 35904290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of anti-inflammatory drugs on splenocyte membrane fluidity.
    Ferreira H; Lúcio M; Lima JL; Cordeiro-da-Silva A; Tavares J; Reis S
    Anal Biochem; 2005 Apr; 339(1):144-9. PubMed ID: 15766721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of liposomes as membrane models to evaluate the contribution of drug-membrane interactions to antioxidant properties of etodolac.
    Lúcio M; Ferreira H; Lima JL; Reis S
    Redox Rep; 2008; 13(5):225-36. PubMed ID: 18796242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSAIDs interactions with membranes: a biophysical approach.
    Nunes C; Brezesinski G; Pereira-Leite C; Lima JL; Reis S; Lúcio M
    Langmuir; 2011 Sep; 27(17):10847-58. PubMed ID: 21790169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam.
    Banerjee R; Chakraborty H; Sarkar M
    Spectrochim Acta A Mol Biomol Spectrosc; 2003 Apr; 59(6):1213-22. PubMed ID: 12659890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.